Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Preparing an Ebola vaccination in Goma in August. Photo: Augustin Wamenya/AFP/Getty Images

The Democratic Republic of the Congo has decided to allow a second Ebola vaccine to be distributed to certain areas of its country — a move that the World Health Organization praised as a key tool to halting further expansion of the deadly virus.

Why it matters: The DRC initially resisted some of the recommendations from the WHO, including one to approve testing another experimental vaccine. But DRC's new leader of the Ebola response in the Ministry of Health is trying new activities to halt the outbreak, which as of Sept. 19 killed about 2,111 people and infected roughly 3,157 people (in both probable and confirmed infections).

“The DRC authorities, in deciding to deploy the second experimental vaccine to extend protection against this deadly virus, have once again shown leadership and their determination to end this outbreak as soon as possible.”
— WHO Director-General Tedros Adhanom Ghebreyesus, in statement

Details: The DRC will introduce the second experimental vaccine made by Johnson & Johnson starting in mid-October, the WHO says. It will complement the current vaccine made by Merck, which is also experimental but has preliminary results showing high effectiveness.

  • J&J's vaccine was initially considered to be harder to distribute logistically, since it requires 2 doses given 56 days apart — tough to do especially in areas with a highly mobile population and many refugees.
  • However, the DRC is planning to use this experimental vaccine in communities outside of the Ebola hot spots in an effort to prevent the outbreak from reaching new regions.

Meanwhile, the WHO issued a statement Saturday warning that there may be at least one undiagnosed case in Tanzania, adding that it is trying to discern the situation there but were finding Tanzanian officials unresponsive to its requests for more information.

Go deeper:

Go deeper

2 hours ago - Health

Boris Johnson announces month-long COVID-19 lockdown in England

Prime Minsiter Boris Johnson. Photo: NurPhoto / Getty Images

A new national lockdown will be imposed in England, Prime Minister Boris Johnson announced Saturday, as the number of COVID-19 cases in the country topped 1 million.

Details: Starting Thursday, people in England must stay at home, and bars and restaurants will close, except for takeout and deliveries. All non-essential retail will also be shuttered. Different households will be banned from mixing indoors. International travel, unless for business purposes, will be banned. The new measures will last through at least December 2.

Updated 2 hours ago - Politics & Policy

The massive early vote

Illustration: Sarah Grillo/Axios

Early voting in the 2020 election across the U.S. on Saturday had already reached 65.5% of 2016's total turnout, according to state data compiled by the U.S. Elections Project.

Why it matters: The coronavirus pandemic and its resultant social-distancing measures prompted a massive uptick in both mail-in ballots and early voting nationwide, setting up an unprecedented and potentially tumultuous count in the hours and days after the polls close on Nov. 3.

Updated 3 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: Ipsos poll: COVID trick-or-treat.
  2. World: Greece tightens coronavirus restrictions as Europe cases spike — Austria reimposes coronavirus lockdowns amid surge of infections
  3. Economy: Conference Board predicts economy won’t fully recover until late 2021.
  4. Technology: Fully at-home rapid COVID test to move forward.
  5. States: New York rolls out new testing requirements for visitors.